Facts about LEO Pharma
This is a compilation of fast facts about LEO Pharma. If you require further information, please refer to our media contact.
What - focus areas, products, pipeline and financial figures
Where – headquarters, global presence and production plants.
When - LEO Pharma history in brief
Who - management structure, the LEO Foundation and LEO people.
What
LEO Pharma is a Danish research-based pharmaceutical company wholly owned by The LEO Foundation, an independent, mercantile foundation.
Focus Areas
Dermatology:
- Psoriasis
- Eczema
- Skin infections
- Actinic keratosis and non-melanoma skin cancer
Thrombosis:
- Thrombosis
Products
Read more about our Products.
View the most recent version of the LEO Pharma Pipeline.
Financial Figures
Group turnover
2010: DKK 7,245.1 million
2009: DKK 6,081.5 million
2008: DKK 5,709.4 million
2007: DKK 5,245.9 million
Profit before tax
2010: DKK 1,063.6 million
2009: DKK -19.1 million
2008: DKK 3,200.8 million
2007: DKK 2,901.2 million
Net Profit
2010: DKK 699.6 million
2009: DKK -166.5 million
2008: DKK 2,528.2 million
2007: DKK 2,364.5 million
Read more about LEO Pharma Financial Figures.
LEO financial figures 2006-2010.
Where
LEO Pharma is headquartered in Denmark.
Headquarters
LEO Pharma is headquartered in Ballerup, Denmark:
LEO Pharma A/S
Industriparken 55
DK-2750 Ballerup
Denmark
CVR No. 56759514
Tel: +45 44 94 58 88
Fax: +45 72 26 33 21
Contact LEO Pharma headquarters.
Get more details about visiting LEO Pharma, Ballerup, Denmark.
Global presence
LEO People and offices in 58 countries.
Products sold in 100 countries.
You can find the LEO Pharma office nearest to you on the map below.
See LEO global presence.
Production Facilities:
- Ballerup - Denmark
- Esbjerg - Denmark
- Vernouillet, Dreux - France
- Dublin - Ireland
- Wexport, Cork - Ireland
- Southport - Australia
Get details about LEO Production facilities.
When
LEO was established in 1908 in Denmark.
In November 2008, LEO Pharma celebrated its 100th anniversary. LEO Pharma was the first company outside the UK and the US to produce penicillin.
Read more about the LEO History.
Who
Management
Gitte P. Aabo, President and CEO
Lars Olsen, Executive Vice President - Sales and Marketing
John Mehlbye, Executive Vice President - Global Product Supply
Kim Kjøller, Senior Vice President - Global Development
Tore Duvold, Senior Vice President - New Product Discovery
Read more about the LEO Management.
People
4,600 employees worldwide - approx. 1,400 employees are based at the headquarters in Ballerup, Denmark.
- Research & Development: 580
- Global Product Supply: 1150
- Sales & Marketing: 1820
- Support functions: 350
(Headcount. Ultimo March 2011)
LEO People form the basis for LEO Pharma's continued success, and LEO actively supports diversity and encourages the professional growth and development of all employees.
Read more about being employed at LEO Pharma and current Job openings.
LEO Foundation
LEO Pharma is wholly owned by The LEO Foundation, an independent, mercantile foundation.
The objective of the LEO Foundation is to ensure that LEO Pharma, through continuous development and growth, remains an independent and competitive pharmaceutical company.
Read about the LEO Foundation.
